Cash burn high as well, something felt wrong and still feels wrong |
Sold remainder of reduced stake.
IMO management are good & rescued XAR, but new products haven't sold as well as hoped.
P/E ratio extravagant for a business that finds headway so tough and disappoints.
Paid 74.5p in July 2020, so WTF?! |
Feels like someone wants to keep this price up, small trades at the un-crossing at 180 strange? |
All depends on the new aqueous head's success. These have only just hit the market.
They've reorganised well, reorganised their R&D efforts to target that market, cutting that spending and kept a stable financial control so there's no risk of fundraise; just wait and see what the sales come to.
That said, I bought a chunk at c.80p & reduced by a third in May '22 to get my money back - now on a free ride.
In view of the experience of the board in this sector, I'm optimistic about the prospects, tho' we've yet to have firm data/proof os success. |
Results seem to get worse each time despite all the promises |
Rns today sounds positive at least. All to play for in next 6 months |
Bought a few more
This is due a wee rise |
Norges Bank taken a 3% stake - no previous holding. |
New partnership. |
Reassuring update; and potential for upgrades heading forwards. |
Who bought and why it not shown up on volume data |
Schroders notified on Friday after the close that they had reduced by 3% to 24.9%. They may sell more in higher volumes at the next trading update.
Schroders also surprised by reducing in another one of my shares in the last fortnight where they had been adding only a few months earlier |
Reckon next week now. |
14 July last year. |
Should be due a trading update very soon. |
P/E is very high & its' future depends on how well their new products gain traction.
IMO they're on the right track. Sold some recently at a pretty profit
as share price requires hard proof of delivery, but kept the majority. |
Is the P/E currently not 84? |
 Xaar PLC
05 July 2023
5 July 2023
Xaar plc
Commercial partnership with Quantica
Xaar plc ("Xaar" or "the Group"), the leading inkjet printing technology group, and Quantica GmbH ("Quantica"), the multi-material 3D printing firm, have signed an exclusive commercial partnership to manufacture Quantica's NovoJet printheads, enabling ultra high viscosity printing for 2D and 3D printing applications. This partnership combines Xaar's expertise in inkjet printhead manufacturing with Quantica's ultra high viscosity printhead technology.
Manufacturing will take place at Xaar's high-tech facility in Huntingdon, with both companies expecting the initial NovoJet printheads to be shipping in Quantica's first 3D printers from the end of 2023.
The agreement also gives Xaar commercial access to Quantica's IP in the jetting of highly viscous materials at up to 400cP at jetting temperature. This will complement Xaar's existing printheads and ImagineX technology portfolio which already enable jetting up to 100cP - far beyond other printheads available today.
Xaar will now offer the widest capability in printing high-performance materials to its OEM customers, meeting the opportunities for advanced manufacturing applications across electronics, display, industrial coating, adhesive and life-science sectors.
Founded in 2018 in Berlin, Quantica has dedicated its research and development efforts to both the novel NovoJet printhead technology and advanced multi-material 3D printers. By partnering with Xaar, a leader in inkjet printhead manufacturing, Quantica will further focus on the development of its 3D printing systems for applications in dental, medical, electronics, R&D, and more.
Graham Tweedale, Xaar's Chief Operation Officer, said:
"As we continue to accelerate our strategy the combination of our existing ImagineX technologies with the capability offered by Quantica's IP will ensure Xaar offers the widest range of solutions in jetting highly viscous materials."
Ramon Borrell, Chief Technology Officer for Quantica, said :
"Xaar is widely recognised for the quality of its printheads, and this agreement enables us to focus on delivering the roadmap of innovative NovoJet 3D printers for high performance multi-material parts with full confidence the printheads will deliver for our customers and partners." |
Time for me to top up on these |
Bought a few this am. Not showing yet. |
opinions appear to be really split on this stock. possibly as it has some growth elements in there and it also has some recovery elements to it - which make it a bit of a hybrid stock. I share napoleons view that this will go ballistic at some stage as this will very much be a needed technology for those who want to stay in the game. Once their competitors integrate (or switch back to) Xaar's print technology, the others will have to switch. Purely just from a lead time prospective alone (let alone all the other benefits that come with it - cost, quality, efficiency, ESG credentials, etc). Sit tight and hold, possibly also buy on dips at these lower prices (if you dont have a full position in it yet). |
"SCSW like them - 30p eps anticipated in 2025"
Didn't say a broker... |
Which broker is forecasting 30p? Got a link? |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
